Prior to QLS, John Frishkopf was a founder of NewStar Financial, Inc. As the Treasurer and Head of Asset Management he developed NewStar’s risk management and securitization platform, issuing pioneering middle market collateralized loan obligations. Before NewStar, Mr. Frishkopf co-founded Benson Oak, a boutique investment bank focused on innovative international debt capital markets solutions for clients. Mr. Frishkopf has participated in research applying asset securitization techniques to drug development since 2013 and is a member of the board of directors of the National Brain Tumor Society as well as the Global Coalition for Adaptive Research, the sponsor of an adaptive clinical trial for glioblastoma. He holds a B.S. from the Massachusetts Institute of Technology and an M.M.S. from the MIT Sloan School of Management.